| 11938101 |
Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide |
Paul Mollard, Peter Giannousis, Shazad Suchit, Mahmoud Mirmehrabi, Christopher R. Cornell |
2024-03-26 |
$33,437,000 |
| 11840497 |
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
Orion D. Jankowski, Paul Mollard, William D. Shrader |
2023-12-12 |
$29,507,000 |
| 11312697 |
Process for the production of alpha-tocotrienol and derivatives |
Andrew W. Hinman, Orion D. Jankowski |
2022-04-26 |
$23,920,000 |
| 10968166 |
4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
Orion D. Jankowski, Paul Mollard, William D. Shrader |
2021-04-06 |
$33,287,000 |
| 10251847 |
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide |
Paul Mollard, Christopher R. Cornell, Peter Giannousis, Shazad Suchit, Mahmoud Mirmehrabi |
2019-04-09 |
|
| 10189830 |
Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders |
Andrew W. Hinman, Christopher R. Cornell |
2019-01-29 |
|
| 10167251 |
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
Orion D. Jankowski, Paul Mollard, William D. Shrader |
2019-01-01 |
|
| 9932286 |
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
Guy M. Miller, Sidney Hecht, Orion D. Jankowski, Paul Mollard |
2018-04-03 |
|
| 9546132 |
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
Orion D. Jankowski, Paul Mollard, William D. Shrader |
2017-01-17 |
|
| 9486435 |
(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases |
Andrew W. Hinman |
2016-11-08 |
|
| 9278085 |
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
Guy M. Miller, Sidney Hecht, Orion D. Jankowski, Paul Mollard |
2016-03-08 |
|
| 9169196 |
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
Orion D. Jankowski, Paul Mollard, William D. Shrader |
2015-10-27 |
|
| 9162986 |
2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
Aleksandr Kolesnikov, Roopa Rai, William D. Shrader, Steven M. Torkelson, Wendy B. Young |
2015-10-20 |
|
| 9090576 |
2-substituted-p-quinone derivatives for treatment of oxidative stress diseases |
Andrew W. Hinman, Orion D. Jankowski, William D. Shrader, Edgar P. LEE |
2015-07-28 |
|
| 9073873 |
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
Andrew W. Hinman, Orion D. Jankowski |
2015-07-07 |
|
| 8952071 |
(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases |
Andrew W. Hinman |
2015-02-10 |
|
| 8778625 |
2-(2-hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
Aleksandr Kolesnikov, Roopa Rai, William D. Shrader, Steven M. Torkelson, Wendy B. Young |
2014-07-15 |
$38,579,000 |
| 8716486 |
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
Andrew W. Hinman, Orion D. Jankowski |
2014-05-06 |
|
| 8716527 |
2-substituted-p-quinone derivatives for treatment of oxidative stress diseases |
Andrew W. Hinman, Orion D. Jankowski, Paul Mollard, William D. Shrader, Christopher R. Cornell |
2014-05-06 |
|
| 8575369 |
Process for the production of alpha-tocotrienol and derivatives |
Andrew W. Hinman, Orion D. Jankowski |
2013-11-05 |
|
| 8519001 |
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
Orion D. Jankowski, Paul Mollard, William D. Shrader |
2013-08-27 |
|
| 8415328 |
Factor VIIa inhibitor |
Daniel A. Dickman, Dange Vijay Kumar, Colin O'Bryan, Roopa Rai, William D. Shrader |
2013-04-09 |
$59,434,000 |
| 8299110 |
2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors |
Aleksandr Kolesnikov, Roopa Rai, William D. Shrader, Steven M. Torkelson, Wendy B. Young |
2012-10-30 |
|
| 8106223 |
Process for the production of alpha-tocotrienol and derivatives |
Andrew W. Hinman, Orion D. Jankowski |
2012-01-31 |
|
| 7968746 |
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
Orion D. Jankowski, Paul Mollard, William D. Shrader |
2011-06-28 |
|